Pyridazinone-amides derivatives
US-2015376167-A1 · Dec 31, 2015 · US
CDK2 degraders and uses thereof
US12097261B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12097261-B2 |
| Application number | US-202217738556-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 6, 2022 |
| Priority date | May 7, 2021 |
| Publication date | Sep 24, 2024 |
| Grant date | Sep 24, 2024 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention provides compounds, compositions thereof, and methods of using the same.
First claim
Opening claim text (preview).
We claim: 1. A compound of the following formula: or a salt thereof. 2. A compound of any one of the following formulae: or a salt thereof. 3. A compound of any one of the following formulae: or a salt thereof. 4. The compound of claim 2 , wherein the compound is of the following formula: or a salt thereof. 5. The compound of claim 2 , wherein the compound is of the following formula: or a salt thereof. 6. The compound of claim 2 , wherein the compound is of the following formula: or a salt thereof. 7. The compound of claim 3 , wherein the compound is of any one of the following formulae: or a salt thereof. 8. The compound of claim 3 , wherein the compound is of any one of the following formulae: or a salt thereof. 9. The compound of claim 3 , wherein the compound is of any one of the following formulae: or a salt thereof. 10. The compound of claim 3 , wherein the compound is of the following formula: or a salt thereof. 11. The compound of claim 3 , wherein the compound is of any one of the following formulae: or a salt thereof. 12. The compound of claim 3 , wherein the compound is of any one of the following formulae: or a salt thereof.
Assignees
Inventors
Classifications
one oxygen and one nitrogen atom, e.g. guanine · CPC title
containing three or more hetero rings · CPC title
Ortho-condensed systems · CPC title
Antineoplastic agents · CPC title
containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US12097261B2 cover?
- The present invention provides compounds, compositions thereof, and methods of using the same.
- Who is the assignee on this patent?
- Kymera Therapeutics Inc
- What technology area does this patent fall under?
- Primary CPC classification A61K47/55. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Sep 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).